查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439278

關節內替代治療裝置 - 全球市場回顧、競爭格局、市場預測（2030）

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球關節內替代治療器材市場規模預計為40.8億美元，到2030年將達到64.3億美元，2024-2030年預測期內複合年增長率為7.94%，預計將持續增長。 對關節內替代治療裝置的需求不斷增長，主要是由於老年人口的增加和骨關節炎患病率的上升，對非手術治療的需求不斷增加，基於透明質酸的療法的發展取得了進展，並且這是由於明確的報銷內部替代療法的政策。

關節內替代療法的市場動態

根據世界衛生組織 (WHO) (2022) 的數據，2019 年全球約有 5.28 億人患有骨關節炎。 根據同一來源，骨關節炎導致 1900 萬年殘疾 (YLD)。 骨關節炎，也稱為“磨損”，會因關節內軟骨磨損而引起嚴重疼痛、腫脹和其他症狀。

另外，根據澳洲健康與福利研究所（2020）的報告，2017-2018年，每11名澳洲人中就有1人患有骨關節炎，這一數字約為220萬。

因此，由於這些設備有助於減輕關節炎/骨關節炎關節（最常見的是膝蓋）的疼痛和腫脹，全球骨關節炎的發病率正在增加。可能會迅速增長關節內替代治療設備市場。

老年人口的增加是加速關節內替代治療設備市場發展的另一個因素。 例如，根據世界衛生組織（2022）的數據，到 2030 年，全世界至少六分之一的人將年齡在 60 歲或以上。 到2050年，60歲及以上的人口將達到約21億人。 根據美國風濕病學會 (2021) 的數據，骨關節炎在老年人中更為常見，其中 40 歲以上的人最容易患骨關節炎。

2019 年4 月，美國食品藥物管理局(FDA) 發布了TRILURON□ 的上市前審查，這是一種預先裝有透明質酸鈉的一次性注射器，可緩解與骨關節炎相關的疼痛長達六個月。菲迪亞製藥公司。 因此，產品核准的擴大預計也將推動全球關節內替代治療市場的發展。

然而，某些因素，例如與透明質酸治療相關的高成本以及關節內替代療法缺乏效率，預計將對關節內替代治療設備市場的成長構成挑戰。

關節內替代治療裝置市場區隔分析

在關節內替代治療產品領域，單次注射預計將在預測期內成為主導領域。

這是因為單次注射黏稠補充療法產品相對較新，與現有的3-5次注射黏稠補充療法產品相比也具有成本效益。 例如，一項研究表明，與接受五次標準透明質酸注射的患者相比，接受一次穩定透明質酸注射治療的患者有統計學上顯著的改善。

研究也支持使用單次注射產品治療膝關節骨關節炎，對醫療保健系統的經濟影響有所改善。

此外，主要公司增加投資以改善其產品組合以開發先進產品並保持其在市場中的地位也推動了關節內替代治療設備市場的細分增長，這是一個促成因素。 例如，2019年3月，Seikagaku在義大利推出了HyLink□，這是一種單次關節內注射黏稠補充劑，用於治療膝骨關節炎。

因此，上述因素可能會推動對單次注射黏稠補充劑的需求，從而促進 2024-2030 年預測期內關節內替代治療設備市場的成長。

本報告提供了全球關節內替代治療設備市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章關節內置換治療器材市場報告簡介

第二章關節內替代治療設備市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估

第三章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章關節內替代治療器材市場關鍵因素分析

  • 關節內替代治療設備市場驅動因素
    • 骨關節炎盛行率不斷上升
    • 對非手術治療的需求不斷增加
    • 玻尿酸產品的進展
    • 有利的贖回
  • 關節內替代治療設備市場的限制與挑戰
    • 關節內替代療法治療費用高昂
    • 設備效率低下
  • 關節內替代治療設備的市場機會
    • 低收入地區的成長機會
    • 公司拓展市場的策略舉措

第五章關節內建換治療裝置的波特五力分析

第六章關閉內替代治療器材市場佈局

  • 依產品類型
    • 單次注射
    • 注射 3 次
    • 注射 5 次
  • 按最終用戶
    • 醫院
    • 骨科診所
    • 其他
  • 按地區
    • 北美關節內替代治療設備市場規模（2021-2030）
    • 歐洲關節內替代治療設備市場規模（2021-2030）
    • 亞太地區關節內替代治療設備市場規模（2021-2030）
    • 其他地區關節內替代治療設備市場規模（2021-2030）

第七章關節內替代治療器材公司及產品簡介

  • Anika Therapeutics, Inc.
  • SEIKAGAKU CORPORATION
  • Sanofi
  • Zimmer Biomet
  • Smith & Nephew
  • Ferring B.V.
  • Lifecore Biomedical, LLC
  • LG Chem.
  • Fidia Farmaceutici S.p.A
  • OrthogenRx
  • Bioventus
  • DePuy Synthes (Johnson & Johnson)
  • APTISSEN
  • Vivacy
  • KiOmed Pharma
  • BioPolymer GmbH & Co KG
  • ALBOMED® GmbH

第8章KOL瀏覽量

第 9 章專案方法

第10章DelveInsight服務內容

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

Product Code: DIMDCL0068

The viscosupplementation Devices Market By Product Type (Single Injection, Three Injections, and Five Injections), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography is projected to grow at a static CAGR forecast till 2030 due to the growing prevalence of osteoarthritis across the globe and rising demand for non-surgical treatment options for osteoarthritis.

The global viscosupplementation devices market was valued at USD 4.08 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 6.43 billion by 2030. The rise in demand for Viscosupplementation Devices is primarily attributed to the rising prevalence of osteoarthritis coupled with the growing old age population, growing demand for non-surgical treatment, increasing advancements in the development of hyaluronic acid-based therapies, and well-defined reimbursement policy for viscosupplements, among others.

Viscosupplementation Devices Market Dynamics:

According to the World Health Organization 2022, worldwide around 528 million people were suffering from osteoarthritis in 2019. As per the same source osteoarthritis contributed to 19 million years lived with disability (YLDs). Osteoarthritis also known as "wear and tear" disease is associated with symptoms such as extreme pain, swelling, and others caused by the wearing down of cartilage within the joints.

Moreover, according to the Australian Institute of Health and Welfare 2020 report, between the years 2017 to 2018, one in eleven Australians have osteoarthritis which makes approximately 2.2 million people in the nation.

Therefore, rising osteoarthritis among the population is likely to surge the global viscosupplementation devices market as these devices help reduce pain and swelling in the arthritic/osteoarthritic joint (most commonly, the knee).

The increasing geriatric population is another factor accelerating the market for viscosupplementation devices market. For instance, according to WHO 2022, it has been expected that, globally by 2030, out of 6 at least 1 person will have his/her age 60 years or above. As per the same source, by 2050, the number of people aged 60 years or above will reach around 2.1 billion. The fact mentioned by the American College of Rheumatology 2021, says that osteoarthritis commonly occurs in the old age population and people aged 40 or above are most likely to suffer from it.

In April 2019, the US Food & Drug Administration (FDA) granted Fidia Pharma premarket approval for TRILURON(TM), a single-use syringe, prefilled with sodium hyaluronate to provide relief to the pain associated with osteoarthritis for up to six months. Thus, growing product approvals is also projected to boost the global market for the viscosupplementation market.

However, certain factors such as the high cost associated with hyaluronic acid therapy and the lack of efficiency of the viscosupplementation devices are expected to pose a challenge to the viscosupplementation devices market growth.

Viscosupplementation Devices Market Segment Analysis:

Viscosupplementation Devices Market By Product Type (Single Injection, Three Injections, and Five Injections), End-User (Hospitals, Orthopaedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the viscosupplementation devices product segment, the single injection is expected to emerge as a foremost segment during the forecasted period.

This is because single injection viscosupplementation products are relatively newer and are also cost-effective in comparison to already existing 3-5 injection viscosupplementation products. For instance, as per research studies, a statistically significant improvement was observed for patients treated with a single stabilized hyaluronic acid injection versus those who received standard hyaluronic acid in five injections.

Also, the studies support the use of single injection products in the treatment of knee OA and found a slight improvement in the economic impact on the healthcare system.

Furthermore, rising investments by key players for improving the product portfolio to develop advanced products and to maintain market position is also a driving factor for the segmental growth of the viscosupplementation devices market. For instance, in March 2019, Seikagaku launched HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Italy.

Thus, the above-mentioned factors are likely to propel the demand for single injection viscosupplementation, thereby contributing to the growth of the viscosupplementation devices market during the forecast period from 2024-2030.

North America is expected to dominate the overall Viscosupplementation Devices Market:

Among all the regions, North America is estimated to account for the largest share of the viscosupplementation devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of osteoarthritis, the growing burden of the old age population, sophisticated healthcare infrastructure, the presence of key players in the market, and fast regulatory approval for new products, in the region, the market for viscosupplementation devices is expected to grow during the forecast period 2024-2030.

The increasing patient population suffering from osteoarthritis is the key factor accelerating the growth of the viscosupplementation devices market in the region. The data published by the Centers for Disease Control and Prevention (CDC) 2020 states that approximately 32.5 million US adults are suffering from osteoarthritis.

The growing burden of the geriatric population is further going to increase the demand for viscosupplementation devices in the region. According to the data provided by the World Bank 2022, about 17% of US citizens aged 65 and above in 2021. Also, according to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US. As per the Arthritis by the Numbers report published by the Arthritis Foundation 2019, the risk for knee osteoarthritis increases with age and the annual incidence of knee OA is highest between 55 and 64 years old.

Hence, the above-mentioned factors are going to increase the growth of the viscosupplementation devices market in the region.

Viscosupplementation Devices Market Key Players:

Some of the key market players operating in the viscosupplementation devices market include Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Sanofi, Zimmer Biomet, Smith & Nephew, Ferring B.V., Lifecore Biomedical, LLC, LG Chem, Fidia Farmaceutici S.p.A, OrthogenRx, Bioventus, DePuy Synthes (Johnson & Johnson), Vivacy, APTISSEN, KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED® GmbH and others.

Recent Developmental Activities in the Viscosupplementation Devices Market:

In August 2022, Seikagaku announced the launch of HyLink®, an Intra-Articular Single Injection Viscosupplement for the treatment of knee osteoarthritis in Taiwan.

In January 2022, Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare commercially launched NeoVisc+ 2 mL and NeoVisc ONE 4 mL in Canada for the treatment and improvement of joint functionality and pain in patients suffering from degenerative or mechanical arthropathy of the knees.

Key Takeaway from the Viscosupplementation Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Viscosupplementation Devices Market.

Various opportunities available for the other competitor in the Viscosupplementation Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Viscosupplementation Devices market growth in the coming future?

Target Audience who can be benefited from the Viscosupplementation Devices Market Report Study

Viscosupplementation Devices providers

Research organizations and consulting companies

Viscosupplementation Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in viscosupplementation devices

Various End-users who want to know more about the viscosupplementation devices market and the latest technological developments in the viscosupplementation devices market.

Frequently Asked Questions for Viscosupplementation Devices Market:

1. What are viscosupplementation devices?

Viscosupplementation devices are preparations that have hyaluronic acid filled in an injection, which is administered into the knee joint to relieve pain associated with osteoarthritis.

2. What is the market for global viscosupplementation devices?

The global viscosupplementation devices market was valued at USD 4.08 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 6.43 billion by 2030.

3. What are the drivers for the global viscosupplementation devices market?

The major factors driving the demand for viscosupplementation devices are the rising worldwide prevalence of musculoskeletal disorders such as osteoarthritis, the increasing old age population, recent product approvals, and growing demand for non-surgical osteoarthritis treatment, among others.

4. Who are the key players operating in global viscosupplementation devices?

Some of the key market players operating in the viscosupplementation devices market include Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Sanofi, Zimmer Biomet, Smith & Nephew, Ferring B.V., Lifecore Biomedical, LLC, LG Chem, Fidia Farmaceutici S.p.A, OrthogenRx, Bioventus, DePuy Synthes (Johnson & Johnson), Vivacy, APTISSEN, KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED® GmbH, and others.

5. Which region has the highest share in the viscosupplementation devices market?

North America is expected to dominate the overall viscosupplementation devices market. This domination is due to the favorable reimbursement scenario, advanced healthcare infrastructure, and developed research & development facilities in the region.

Table of Contents

1. Viscosupplementation Devices Market Report Introduction

2. Viscosupplementation Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Viscosupplementation Devices Market Key Factors Analysis

  • 4.1. Viscosupplementation Devices Market Drivers
    • 4.1.1. Rising prevalence of osteoarthritis
    • 4.1.2. Increase in demand for non-surgical treatment
    • 4.1.3. Rising advancement in hyaluronic acid-based products
    • 4.1.4. Favorable reimbursement
  • 4.2. Viscosupplementation Devices Market Restraints and Challenges
    • 4.2.1. High cost of the Viscosupplementation Treatment
    • 4.2.2. The inefficiency of the Device
  • 4.3. Viscosupplementation Devices Market Opportunities
    • 4.3.1. Growth opportunities in low-income regions
    • 4.3.2. Strategic initiatives by Companies for Market Expansion

5. Viscosupplementation Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes 5.5 Competitive Rivalry

6. Viscosupplementation Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Single Injection
    • 6.1.2. Three Injections
    • 6.1.3. Five Injections
  • 6.2. By End-User
    • 6.2.1. Hospitals
    • 6.2.2. Orthopedic Clinics
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Viscosupplementation Devices Market Size in USD million (2021-2030)
    • 6.3.2. Europe Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.1. France Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Viscosupplementation Devices Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.1. China Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.3. India Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia Pacific Viscosupplementation Devices Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Viscosupplementation Devices Market Size in USD million (2021-2030)

7. Viscosupplementation Devices Company and Product Profiles

  • 7.1. Anika Therapeutics, Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. SEIKAGAKU CORPORATION
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Sanofi
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Zimmer Biomet
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Smith & Nephew
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Ferring B.V.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Lifecore Biomedical, LLC
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. LG Chem.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Fidia Farmaceutici S.p.A
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. OrthogenRx
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Bioventus
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. DePuy Synthes (Johnson & Johnson)
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. APTISSEN
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Vivacy
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. KiOmed Pharma
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. BioPolymer GmbH & Co KG
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. ALBOMED® GmbH
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Viscosupplementation Devices Market in Global (2021-2030)
  • Table 3: Viscosupplementation Devices Market in Global by Product Type (2021-2030)
  • Table 4: Viscosupplementation Devices Market in Global by End-User (2021-2030)
  • Table 5: Viscosupplementation Devices Market in Global by Geography (2021-2030)
  • Table 6: Viscosupplementation Devices Market in North America (2021-2030)
  • Table 7: Viscosupplementation Devices Market in the US (2021-2030)
  • Table 8: Viscosupplementation Devices Market in Canada (2021-2030)
  • Table 9: Viscosupplementation Devices Market in Mexico (2021-2030)
  • Table 10: Viscosupplementation Devices Market in Europe (2021-2030)
  • Table 11: Viscosupplementation Devices Market in France (2021-2030)
  • Table 12: Viscosupplementation Devices Market in Germany (2021-2030)
  • Table 13: Viscosupplementation Devices Market in the United Kingdom (2021-2030)
  • Table 14: Viscosupplementation Devices Market in Italy (2021-2030)
  • Table 15: Viscosupplementation Devices Market in Spain (2021-2030)
  • Table 16: Viscosupplementation Devices Market in Rest of Europe (2021-2030)
  • Table 17: Viscosupplementation Devices Market in Asia-Pacific (2021-2030)
  • Table 18: Viscosupplementation Devices Market in China (2021-2030)
  • Table 19: Viscosupplementation Devices Market in Japan (2021-2030)
  • Table 20: Viscosupplementation Devices Market in India (2021-2030)
  • Table 21: Viscosupplementation Devices Market in Australia (2021-2030)
  • Table 22: Viscosupplementation Devices Market in South Korea (2021-2030)
  • Table 23: Viscosupplementation Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Viscosupplementation Devices Market in the Rest of World (2021-2030)
  • Table 25: Viscosupplementation Devices Market in the Middle East (2021-2030)
  • Table 26: Viscosupplementation Devices Market in Africa (2021-2030)
  • Table 27: Viscosupplementation Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Viscosupplementation Devices Market in Global (2021-2030)
  • Figure 3: Viscosupplementation Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Viscosupplementation Devices Market in Global by End-User (2021-2030)
  • Figure 5: Viscosupplementation Devices Market in Global by Geography (2021-2030)
  • Figure 6: Viscosupplementation Devices Market in North America (2021-2030)
  • Figure 7: Viscosupplementation Devices Market in the US (2021-2030)
  • Figure 8: Viscosupplementation Devices Market in Canada (2021-2030)
  • Figure 9: Viscosupplementation Devices Market in Mexico (2021-2030)
  • Figure 10: Viscosupplementation Devices Market in Europe (2021-2030)
  • Figure 11: Viscosupplementation Devices Market in France (2021-2030)
  • Figure 12: Viscosupplementation Devices Market in Germany (2021-2030)
  • Figure 13: Viscosupplementation Devices Market in the United Kingdom (2021-2030)
  • Figure 14: Viscosupplementation Devices Market in Italy (2021-2030)
  • Figure 15: Viscosupplementation Devices Market in Spain (2021-2030)
  • Figure 16: Viscosupplementation Devices Market in Rest of Europe (2021-2030)
  • Figure 17: Viscosupplementation Devices Market in Asia-Pacific (2021-2030)
  • Figure 18: Viscosupplementation Devices Market in China (2021-2030)
  • Figure 19: Viscosupplementation Devices Market in Japan (2021-2030)
  • Figure 20: Viscosupplementation Devices Market in India (2021-2030)
  • Figure 21: Viscosupplementation Devices Market in Australia (2021-2030)
  • Figure 22: Viscosupplementation Devices Market in South Korea (2021-2030)
  • Figure 23: Viscosupplementation Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Viscosupplementation Devices Market in the Rest of the World (2021-2030)
  • Figure 25: Viscosupplementation Devices Market in the Middle East (2021-2030)
  • Figure 26: Viscosupplementation Devices Market in Africa (2021-2030)
  • Figure 27: Viscosupplementation Devices Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities
  • Figure 31: PORTER's Five Force Analysis